The influence of magnetised electron transport on thermal self-focusing and channelling of nanosecond laser beams

The propagation of a nanosecond IR laser pulse through an under-dense (0.01 — 0.1ncr) magnetised laser-plasma is considered. The interplay between magnetised transport, B-field evolution and plasma hydrodynamics in the presence of a dynamically evolving beam are investigated by means of a paraxial wave solving module coupled to CTC, a 2D MHD code including Braginskii electron transport and IMPACT, a 2D implicit Vlasov-Fokker-Planck (VFP) code with magnetic fields. Magnetic fields have previously been shown to improve density channel formation for plasma waveguides however fluid simulations presented here indicate that Nernst advection can result in the rapid cavitation of magnetic field in the laser-heated region resulting in beam defocusing. Kinetic simulations indicate that strong non-local transport is present leading to the fluid code overestimating heat-flow and magnetic field advection and resulting in the recovery of beam channelling for the conditions considered

Scaling laws for electron kinetic effects in tokamak scrape-off layer plasmas

Tokamak edge (scrape-off layer (SOL)) plasmas can exhibit non-local transport in the direction parallel to the magnetic field due to steep temperature gradients. This effect along with its consequences has been explored at equilibrium for a range of conditions, from sheath-limited to detached, using the 1D kinetic electron code SOL-KiT, where the electrons are treated kinetically and compared to a self-consistent fluid model. Line-averaged suppression of the kinetic heat flux (compared to Spitzer-Härm) of up to 50% is observed, contrasting with up to 98% enhancement of the sheath heat transmission coefficient, γe. Simple scaling laws in terms of basic SOL parameters for both effects are presented. By implementing these scalings as corrections to the fluid model, we find good agreement with the kinetic model for target electron temperatures. It is found that the strongest kinetic effects in γe are observed at low-intermediate collisionalities, and tend to increase (keeping upstream collisionality fixed) at increasing upstream densities and temperatures. On the other hand, the heat flux suppression is found to increase monotonically as upstream collisionality decreases. The conditions simulated encompass collisionalities relevant to current and future tokamaks

Kinetic and fluid simulations of parallel electron transport during equilibria and transients in the scrape-off layer

We present the first parallel electron transport results obtained using the newly developed 1D transport code SOL-KiT. With the capability to switch between consistent kinetic and fluid models for the electrons, we explore and report the differences in both equilibrium and transient simulations. Significant kinetic effects are found during transients, especially in the behaviour of the electron sheath heat transmission coefficient, which shows up to an eightfold increase. Equilibria are obtained for an input power scan with parameters relevant to medium size tokamaks. Detached equilibria are found to persist to higher input powers when electrons are treated kinetically. Furthermore, non-monotonic behaviour of the electron sheath heat transmission coefficient is observed in the power scan, with values being up to 40% above the classical value. We discuss the implications of the p

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases

Background. Endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD) are both used to resolve jaundice before surgery for perihilar cholangiocarcinoma (PHC). PTBD has been associated with seeding metastases. The aim of this study was to compare overall survival (OS) and the incidence of initial seeding metastases that potentially influence survival in patients with preoperative PTBD versus EBD. Methods. Between 1991 and 2012, a total of 278 patients underwent preoperative biliary drainage and resection of PHC at 2 institutions in the Netherlands and the United States. Of these, 33 patients were excluded for postoperative mortality. Among the 245 included patients, 88 patients who underwent preoperative PTBD (with or without previous EBD) were compared to 157 patients who underwent EBD only. Survival analysis was done with Kaplan-Meier and Cox regression with propensity score adjustment. Results. Unadjusted median OS was comparable between the PTBD group (35 months) and EBD-only group (41 months; P = 0.26). After adjustment for propensity score, OS between the PTBD group and EBD-only group was similar (hazard ratio, 1.05; 95 % confidence interval, 0.74-1.49; P = 0.80). Seeding metastases in the laparotomy scar occurred as initial recurrence in 7 patients, including 3 patients (3.4 %) in the PTBD group and 4 patients (2.7 %) in the EBD-only group (P = 0.71). No patient had an initial recurrence in percutaneous catheter tracts. Conclusions. The present study found no effect of PTBD on survival compared to patients with EBD and no increase in seeding metastases that developed as initial recurrence. These data suggest that PTBD can safely be used in preoperative management of PHC

Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete

BACKGROUND: An increased prevalence of coeliac disease in patients with primary biliary cirrhosis has been recently reported. However, in other studies the association has not been confirmed. There have been no formal attempts to systematically evaluate patients with autoimmune cholangitis for coeliac disease. METHODS: Sera from 62 patients with primary biliary cirrhosis, 17 with autoimmune cholangitis and 100 blood donors were screened for anti-gliadin, anti-endomysial, anti-reticulin, and IgA class antibodies to guinea pig liver-derived tissue transglutaminase. Eighteen untreated coeliacs served as methodological controls. Analyses were performed by using the χ(2) and Fischer's exact tests. RESULTS: Anti-gliadin antibodies were detected in 21% of patients with primary biliary cirrhosis, 35% of patients with autoimmune cholangitis, and 3% of controls (p < 0.001). IgA class gliadin antibodies positivity was more pronounced in patients with Scheuer's stage III-IV disease (p < 0.05). Anti-transglutaminase antibodies were detected in 10% and in 18% of patients with primary biliary cirrhosis and autoimmune cholangitis respectively (p < 0.001). Anti-reticulin and anti-endomysial antibodies were negative in all patients. Duodenal biopsies were performed in 59% and 71% of patients with primary biliary cirrhosis and autoimmune cholangitis respectively, tested positive for at least one antibody class. No histological features of coeliac disease were found. CONCLUSIONS: We were unable to demonstrate an increased risk of coeliac disease in patients with primary biliary cirrhosis and autoimmune cholangitis. Our results confirm the previously reported high prevalence of false-positive anti-gliadin and guinea pig liver-derived anti-tissue transglutaminase antibodies in patients with chronic liver disease

A Recombinant Avian Infectious Bronchitis Virus Expressing a Heterologous Spike Gene Belonging to the 4/91 Serotype

We have shown previously that replacement of the spike (S) gene of the apathogenic IBV strain Beau-R with that from the pathogenic strain of the same serotype, M41, resulted in an apathogenic virus, BeauR-M41(S), that conferred protection against challenge with M41 [1]. We have constructed a recombinant IBV, BeauR-4/91(S), with the genetic backbone of Beau-R but expressing the spike protein of the pathogenic IBV strain 4/91(UK), which belongs to a different serogroup as Beaudette or M41. Similar to our previous findings with BeauR-M41(S), clinical signs observations showed that the S gene of the pathogenic 4/91 virus did not confer pathogenicity to the rIBV BeauR-4/91(S). Furthermore, protection studies showed there was homologous protection; BeauR-4/91(S) conferred protection against challenge with wild type 4/91 virus as shown by the absence of clinical signs, IBV RNA assessed by qRT-PCR and the fact that no virus was isolated from tracheas removed from birds primarily infected with BeauR-4/91(S) and challenged with IBV 4/91(UK). A degree of heterologous protection against M41 challenge was observed, albeit at a lower level